Status:
COMPLETED
Self-assessment of Olfactory Disorders for French Speaking Patients
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Post-viral Anosmia
Post-traumatic Anosmia
Eligibility:
All Genders
18+ years
Brief Summary
Sense of smell disorders are common and are said to affect up to 20% of the general population. They are often disabling and have a real impact on the quality of life. Smell disorders are most often a...
Eligibility Criteria
Inclusion
- Patient \> 18 years old
- Patient affiliated to a sickness insurance social protection scheme, beneficiary or rightful claimant
- Patient who has not expressed his or her opposition to the collection and processing of his or her data for research purposes after the investigator has provided informed information.
- Patient presenting an olfactory dysfunction of any acquired aetiology that has been evolving for at least 3 months without total recovery (case group).
- Patient with no sense of smell problems followed up in ENT for another pathology that does not affect the sense of smell (control group).
Exclusion
- Patient in an emergency or life-threatening situation
- Patient under judicial protection
- Patient under guardianship or trusteeship
- Inability to provide informed information to the patient (patient does not speak or understand French)
- Patient with congenital syndromic or non-syndromic congenital anosmia
Key Trial Info
Start Date :
January 22 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 22 2022
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT04705805
Start Date
January 22 2021
End Date
April 22 2022
Last Update
April 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Les Hôpitaux Universitaires de Strasbourg
Strasbourg, France, 67098